The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy ; volume:28 ; number:3 ; day:25 ; month:2 ; year:2014 ; pages:285-295 ; date:6.2014
BioDrugs ; 28, Heft 3 (25.2.2014), 285-295, 6.2014
- Creator
-
Spandonaro, Federico
Ayala, Fabio
Berardesca, Enzo
Chimenti, Sergio
Girolomoni, Giampiero
Martini, Patrizia
Peserico, Andrea
Polistena, Barbara
Puglisi Guerra, Antonio
Vena, Gino Antonio
Altomare, Gianfranco
Calzavara Pinton, Piergiacomo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-014-0084-3
- URN
-
urn:nbn:de:101:1-2019090202390417334458
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spandonaro, Federico
- Ayala, Fabio
- Berardesca, Enzo
- Chimenti, Sergio
- Girolomoni, Giampiero
- Martini, Patrizia
- Peserico, Andrea
- Polistena, Barbara
- Puglisi Guerra, Antonio
- Vena, Gino Antonio
- Altomare, Gianfranco
- Calzavara Pinton, Piergiacomo
- SpringerLink (Online service)
Other Objects (12)
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK
Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
The Sense of Stigmatization in Patients with Plaque Psoriasis
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
The content validity of the PSS in patients with plaque psoriasis
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK
Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
The Sense of Stigmatization in Patients with Plaque Psoriasis
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
The content validity of the PSS in patients with plaque psoriasis
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK
Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
The Sense of Stigmatization in Patients with Plaque Psoriasis
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
The content validity of the PSS in patients with plaque psoriasis
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study